NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation

Xiao-Bo Lai1,2, Yu-Qiang Nie1,2, Hong-Li Huang1,2

  • 1Department of Gastroenterology and Hepatology, The First Municipal People's Hospital of Guangzhou, Guangzhou Medical University, Guangzhou, Guangdong 510180, P.R. China.

Oncology Letters
|April 30, 2017
PubMed

Insights

NIMA-related kinase 2 (Nek2) is overexpressed in hepatocellular carcinoma (HCC), driving cancer growth and proliferation. Inhibiting Nek2 shows promise as a novel therapeutic strategy for HCC by impacting cell cycle and apoptosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • NIMA-related kinase 2 (Nek2) is frequently upregulated in human cancers.
  • Nek2 plays critical roles in cell cycle regulation, gene expression, and centrosome function.
  • Hepatocellular carcinoma (HCC) is a major global health concern with a need for novel therapeutic targets.

Purpose of the Study:

  • To investigate the expression pattern, clinical significance, and biological function of Nek2 in HCC.
  • To determine the role of Nek2 in HCC cell proliferation, cell cycle progression, and apoptosis.
  • To explore the molecular mechanisms underlying Nek2's function in HCC, including its effect on key signaling pathways.

Main Methods:

  • Analysis of Nek2 mRNA and protein levels in HCC and normal liver tissues.
  • In vitro assays including MTT, soft agar colony formation, and flow cytometry to assess cell proliferation and growth.
  • Western blot analysis to evaluate the expression of cell cycle-related proteins (e.g., c-Myc, cyclins, p27) and β-catenin.
  • RNA interference (siRNA) to inhibit Nek2 expression in HepG2 HCC cells.

Main Results:

  • Nek2 expression was significantly upregulated in HCC tissues and cell lines compared to normal controls.
  • Inhibition of Nek2 by siRNA suppressed HCC cell proliferation, colony formation, and induced apoptosis.
  • Nek2 depletion led to G2/M cell cycle arrest, downregulation of β-catenin, c-Myc, cyclins D1, B1, E, and cyclin-dependent kinase 1, and upregulation of p27.
  • Overexpression of Nek2 correlates with the malignant progression of HCC.

Conclusions:

  • Nek2 is a key driver of HCC progression and is associated with poor clinical outcomes.
  • Targeting Nek2 can inhibit HCC cell growth and proliferation.
  • Nek2 may exert its oncogenic effects by regulating the Wnt/β-catenin pathway and downstream targets like c-Myc and cyclins.
  • Nek2 represents a potential novel therapeutic target for hepatocellular carcinoma treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K